Arnicare Product Line Expands With New Homeopathic Arthritis Cream
Arnicare Arthritis Cream is supplied in a 2.5oz tube and retails for $17.99.
Diagnosis & Disease Information
Musculoskeletal Pain Symptoms Common in Menopause
Fiona Watt, PhD, discusses findings of a review examining associations between changes in sex hormones with musculoskeletal pain and painful osteoarthritis. Credit: Getty Images
Motive Knee, a Muscle Stimulation Device for Knee Pain Relief, Now Available
The Motive Knee device is intended to strengthen the quadriceps muscles using neuromuscular electrical stimulation to provide knee pain relief.
Hidden Drugs Found in 3 Supplements Promoted for Joint Pain, Arthritis
Fast-Act Rheuma Capsule, New Fast-Act Rheumatism Capsule, and UA-Block contain active hidden drug ingredients not listed on the product label.
Fracture Risk Reduction Greater With Denosumab vs Alendronate, According to Real-World Data
Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types.
FDA Clears Implantable Shock Absorber to Treat Knee Osteoarthritis
The device is implanted subcutaneously during an outpatient-compatible procedure.
One-Time Gene Therapy Fast Tracked for Duchenne Muscular Dystrophy
RGX-202 is an investigational one-time gene therapy designed to deliver a transgene for a novel microdystrophin.
Turalio Dosing Regimen Updated for Tenosynovial Giant Cell Tumor
A new dosing regimen for Turalio® (pexidartinib) is now available for the treatment of adults with symptomatic tenosynovial giant cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery. The recommended dose of Turalio is now 250mg orally twice daily (taken as two 125mg capsules) with a low-fat meal…
Kevzara Approved for Polymyalgia Rheumatica
The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper.
Myostatin-Targeting Biologic Fast Tracked for Spinal Muscular Atrophy
The Company is currently evaluating the efficacy and safety of taldefgrobep alfa in patients with SMA in the phase 3 RESILIENT study.
- Loading...
Loading...
Loading... 
Loading...